Clinical Trial

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-22 -> 2027-09-30 2026-08-13
minor Completion pushed: 2026-11 -> 2027-11 2026-08-13
Trial Details
NCT Number NCT03680677
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Leukemia, Acute, MDS
Enrollment 20 participants
Start Date 2018-09-21
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-12